Back to all people

Jianjin Xu

FDA

3 appearances in the program

Sessions & presentations

PS11: Perspectives on Using in Silico Simulation in Oncology Drug Development

Parallel · Thu, Sep 17 , 2:45 PM

Co-Organizer

PS11: Perspectives on Using in Silico Simulation in Oncology Drug Development

Parallel · Thu, Sep 17 , 2:45 PM

Chair

PS28: Role of Covariate adjustment in Oncology Trials – Key learnings and opportunities

Parallel · Fri, Sep 18 , 8:30 AM

Discussant

↑